3 Undervalued Biotechnology Stocks for Tuesday, October 08
Discover the top 3 undervalued Biotechnology stocks for Tuesday, October 08 based on AAII’s Stock Grades.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jack Gilleland
Jenna Brashear
Jack Gilleland
| Share Statistics | AQB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $12.0 | $211.8 | 8% |
|
| Shares Out (Mil) | 5.2 | 55.4 | 15% |
|
| Institutional Ownership | 94.7% | 93.0% | 65% |
|
| Float (Mil) | 13.3 | 41.5 | 23% |
|
| Beta | na | 0.99 | na |
|
| Avg Daily Volume (000s) | 61 | 553 | 31% |
|
| Price Change (52-week) |
(18.9%) | 42.8% | 36% |
|
| Growth | AQB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.2% | na |
|
| Net Income (5yr) | (2.4%) | (10.3%) | 37% |
|
| EPS (5yr) | 12.0% | 15.8% | 51 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (73.3%) | (15.7%) | 2% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AQB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $41 | na |
|
| Net Income (TTM) (Mil) | ($19) | ($44) | 24% |
|
| EPS (TTM) | ($3.931) | ($1.500) | 9% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($35) | 23% |
|
| Net Cash Flow (TTM) (Mil) | na | $-0 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $13 | $147 | 9% |
|
| Valuation | AQB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.74 | 2.01 | 80% |
|
| P/E | na | 17.9 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | AQB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.9% | na |
|
| Net Margin | na | (50.6%) | na |
|
| ROA | (108.3%) | (47.4%) | 5% |
|
| ROE | (279.1%) | (53.1%) | 3% |
|
| Liabilities to Assets | 90.0% | 29.7% | 86% |
|
| F-Score | 2 | 3 | 7% |
|
AquaBounty Technologies, Inc. did not pass any screens on 11/13/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors